Linperlisib

linperlisib · Shanghai YingLi Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Linperlisib, covering 2022-10-21 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Linperlisib Combined With Chidamide in Patients With PTCL [Phase 1, Phase 2]